Editorial
Exceptional cancer responders: A zone-to-go
Daniel Gandia and Cecilia Suárez*
Published: 04 January, 2023 | Volume 7 - Issue 1 | Pages: 001-002
Cancer is a disease that implies several different genotypic and phenotypic traits in its whole process of development: tumorigenesis.
Read Full Article HTML
DOI: 10.29328/journal.acst.1001033
Cite this Article
Read Full Article PDF
Keywords:
Cancer; Neoplasms; Exceptional responders; Tumor resistance; Precision medicine
References
- Flobak Å, Skånland SS, Hovig E, Taskén K, Russnes HG. Functional precision cancer medicine: drug sensitivity screening enabled by cell culture models. Trends Pharmacol Sci. 2022 Nov;43(11):973-985. doi: 10.1016/j.tips.2022.08.009. Epub 2022 Sep 23. PMID: 36163057.
- Braverman AS. Chemotherapeutic failure: resistance or insensitivity? Ann Intern Med. 1993 Apr 15;118(8):630-2. doi: 10.7326/0003-4819-118-8-199304150-00010. PMID: 8452329.
- Li X, Li M, Huang M, Lin Q, Fang Q, Liu J, Chen X, Liu L, Zhan X, Shan H, Lu D, Li Q, Li Z, Zhu X. The multi-molecular mechanisms of tumor-targeted drug resistance in precision medicine. Biomed Pharmacother. 2022 Jun;150:113064. doi: 10.1016/j.biopha.2022.113064. Epub 2022 May 5. PMID: 35658234.
- Wheeler DA, Takebe N, Hinoue T, Hoadley KA, Cardenas MF, Hamilton AM, Laird PW, Wang L, Johnson A, Dewal N, Miller V, Piñeyro D, Castro de Moura M, Esteller M, Shen H, Zenklusen JC, Tarnuzzer R, McShane LM, Tricoli JV, Williams PM, Lubensky I, O'Sullivan-Coyne G, Kohn EC, Little RF, White J, Malik S, Harris L, Weil C, Chen AP, Karlovich C, Rodgers B, Shankar L, Jacobs P, Nolan T, Hu J, Muzny DM, Doddapaneni H, Korchina V, Gastier-Foster J, Bowen J, Leraas K, Edmondson EF, Doroshow JH, Conley BA, Ivy SP, Staudt LM. Molecular Features of Cancers Exhibiting Exceptional Responses to Treatment. Cancer Cell. 2021 Jan 11;39(1):38-53.e7. doi: 10.1016/j.ccell.2020.10.015. Epub 2020 Nov 19. PMID: 33217343; PMCID: PMC8478080.
Figures: